Anaergia Inc. revised revenue guidance for fiscal 2022. For the year, management expects to show healthy revenue growth of approximately 25% to 35% compared to Fiscal 2021, to between approximately $160 million and $170 million. This is a reduction from previous Fiscal 2022 revenue guidance.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.295 CAD | -.--% | -.--% | +18.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.00% | 35.44M | |
+15.67% | 83.09B | |
+13.06% | 58.72B | |
+14.09% | 23.17B | |
+17.79% | 11.09B | |
+22.34% | 10.93B | |
-12.77% | 5.92B | |
+27.47% | 4.92B | |
+13.71% | 4.59B | |
-1.80% | 2.45B |
- Stock Market
- Equities
- ANRG Stock
- News Anaergia Inc.
- Anaergia Inc. Revises Revenue Guidance for Fiscal 2022